Literature DB >> 12843057

Rotavirus diarrhea severity is related to the VP4 type in Mexican children.

Felipe Mota-Hernández1, Juan José Calva, Claudia Gutiérrez-Camacho, Sofía Villa-Contreras, Carlos F Arias, Luis Padilla-Noriega, Héctor Guiscafré-Gallardo, María de Lourdes Guerrero, Susana López, Onofre Muñoz, Juan F Contreras, Roberto Cedillo, Ismael Herrera, Fernando I Puerto.   

Abstract

This report is of a community-based case control study to assess whether the severity of acute diarrhea by rotavirus (RV) in young children is associated with a particular VP7 (G) or VP4 (P) RV serotype. Five hundred twenty children younger than 2 years of age with diarrhea lasting less than 3 days were age and gender matched with 520 children with no diarrhea. The G and P serotypes were determined with specific monoclonal antibodies, and the VP4 serotype specificity in a subgroup was confirmed by genotyping. Infection with a G3 serotype led to a higher risk of diarrhea than infection with a G1 serotype. Infection with a G3-nontypeable-P serotype was associated with more severe gastroenteritis than infection with a G3 (or G1) P1A[8] serotype. A child with diarrhea-associated dehydration was almost five times more likely to be infected with a G3-nontypeable-P serotype than a child without dehydration (P < 0.001). Moreover, the two predominant monotypes within serotype P1A[8] had significantly different clinical manifestations. In this study, the severity of RV-associated diarrhea was related to different P serotypes rather than to G serotypes. The relationship between serotype and clinical outcomes seems to be complex and to vary among different geographic areas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843057      PMCID: PMC165316          DOI: 10.1128/JCM.41.7.3158-3162.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Typing of human rotavirus VP4 by an enzyme immunoassay using monoclonal antibodies.

Authors:  B S Coulson
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

2.  Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico.

Authors:  L Padilla-Noriega; M Méndez-Toss; G Menchaca; J F Contreras; P Romero-Guido; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; J Calva; M L Guerrero; B S Coulson; H B Greenberg; S López; C F Arias
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

3.  Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.

Authors:  G Menchaca; L Padilla-Noriega; M Méndez-Toss; J F Contreras; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; R Ward; Y Hoshino; S López; C F Arias
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

4.  Unusual diversity of human rotavirus G and P genotypes in India.

Authors:  M Ramachandran; B K Das; A Vij; R Kumar; S S Bhambal; N Kesari; H Rawat; L Bahl; S Thakur; P A Woods; R I Glass; M K Bhan; J R Gentsch
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

5.  The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden.

Authors:  R I Glass; P E Kilgore; R C Holman; S Jin; J C Smith; P A Woods; M J Clarke; M S Ho; J R Gentsch
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

Review 6.  Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development.

Authors:  J R Gentsch; P A Woods; M Ramachandran; B K Das; J P Leite; A Alfieri; R Kumar; M K Bhan; R I Glass
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

7.  Rotavirus G and P types circulating in Brazil: characterization by RT-PCR, probe hybridization, and sequence analysis.

Authors:  J P Leite; A A Alfieri; P A Woods; R I Glass; J R Gentsch
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Neonatal rotavirus infection in Bangladesh: strain characterization and risk factors for nosocomial infection.

Authors:  P E Kilgore; L E Unicomb; J R Gentsch; M J Albert; C A McElroy; R I Glass
Journal:  Pediatr Infect Dis J       Date:  1996-08       Impact factor: 2.129

9.  Rotavirus serotype G5 associated with diarrhea in Brazilian children.

Authors:  V Gouvea; L de Castro; M C Timenetsky; H Greenberg; N Santos
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

10.  Cohort study of rotavirus serotype patterns in symptomatic and asymptomatic infections in Mexican children.

Authors:  F Raúl Velázquez; J J Calva; M Lourdes Guerrero; D Mass; R I Glass; L K Pickering; G M Ruiz-Palacios
Journal:  Pediatr Infect Dis J       Date:  1993-01       Impact factor: 2.129

View more
  4 in total

1.  Rotavirus genotype distribution during the pre-vaccine period in Bolivia: 2007-2008.

Authors:  Rosario Rivera; Kristen Forney; Maria René Castro; Paulina A Rebolledo; Nataniel Mamani; Maritza Patzi; Percy Halkyer; Juan S Leon; Volga Iñiguez
Journal:  Int J Infect Dis       Date:  2013-05-17       Impact factor: 3.623

2.  Prevalence and genetic diversity of human astroviruses in Mexican children with symptomatic and asymptomatic infections.

Authors:  Martha Méndez-Toss; Dixie D Griffin; Juan Calva; Juan F Contreras; Fernando I Puerto; Felipe Mota; Héctor Guiscafré; Roberto Cedillo; Onofre Muñoz; Ismael Herrera; Susana López; Carlos F Arias
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

3.  Genotyping and clinical factors in pediatric diarrhea caused by rotaviruses: one-year surveillance in Surabaya, Indonesia.

Authors:  Subijanto Marto Sudarmo; Katsumi Shigemura; Alpha Fardah Athiyyah; Kayo Osawa; Oktavian Prasetia Wardana; Andy Darma; Reza Ranuh; Dadik Raharjo; Soichi Arakawa; Masato Fujisawa; Toshiro Shirakawa
Journal:  Gut Pathog       Date:  2015-02-08       Impact factor: 4.181

4.  Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico.

Authors:  Atanacio Valencia-Mendoza; Stefano M Bertozzi; Juan-Pablo Gutierrez; Robbin Itzler
Journal:  BMC Infect Dis       Date:  2008-07-29       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.